Real-World Adverse Events Associated with Encapsulated Benzoyl Peroxide/Tretinoin, 3%/0.1%, and Encapsulated Benzoyl Peroxide, 5%

Real-World Adverse Events Associated with Encapsulated Benzoyl Peroxide/Tretinoin, 3%/0.1%, and Encapsulated Benzoyl Peroxide, 5%

Abstract Encapsulated benzoyl peroxide, 5%, for rosacea and a combined formulation of encapsulated benzoyl peroxide/tretinoin, 3%/0.1%, for acne vulgaris, utilize microencapsulation, a process by which active pharmaceutical agents are enclosed in inert, permeable silica shells that provide a buffer...

Full description

Bibliographic Details
Main Authors: Amy Poteate, Ofra Levy-Hacham, J. P. York
Format: Article
Language:English
Published: Adis, Springer Healthcare 2024-01-01
Series:Dermatology and Therapy
Subjects:
Acne vulgaris
Benzoyl peroxide
E-BPO
E-BPO/T
Encapsulated benzoyl peroxide 5%
Encapsulated benzoyl peroxide 3%/tretinoin 0.1%
Online Access:https://doi.org/10.1007/s13555-023-01095-8

Internet

https://doi.org/10.1007/s13555-023-01095-8

Similar Items